insights_auto
Outlook: 72.5% bullish·0.0% bearish
Go to analysischevron_right
ABBV:NYSE
AbbVie Common Stock
$262.82
arrow_upward
+1.11%(+2.89) 1D
$262.82
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:02:33 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV...
Open
$259.74
High
$264.06
Low
$257.87
Mkt. cap
464.43B
Avg. vol.
4.14M
Volume
5.86M
Dividend
2.63%
Quarterly dividend
$1.73
Ex-dividend date
Oct 15, 2026
P/E ratio
74.33
52-wk high
$269.39
52-wk low
$190.75
EPS
$3.54
Beta
0.23
Shares outstanding
1.77B
No. of employees
57K
Open
$259.74
High
$264.06
Low
$257.87
Mkt. cap
464.43B
Avg. vol.
4.14M
Volume
5.86M
Dividend
2.63%
Quarterly dividend
$1.73
Ex-dividend date
Oct 15, 2026
P/E ratio
74.33
52-wk high
$269.39
52-wk low
$190.75
EPS
$3.54
Beta
0.23
Shares outstanding
1.77B
No. of employees
57K
News stories
From web sources and news partners
The Motley Fool
·
8 hours ago
AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.
AD HOC NEWS
·
10 hours ago
AbbVie presents new dermatology data. AbbVie stock costs EUR 233.55 in weekend trading
Zacks
·
20 hours ago
How to Create a Million-Dollar Stock Portfolio
News Corp
·
23 hours ago
AbbVie Inc. stock outperforms competitors on strong trading day
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com